Skip to content

Mechanism research of auricular point therapy for chronic insomnia based on serum proteomics and metabolomics

Mechanism research of auricular point therapy for chronic insomnia based on serum proteomics and metabolomics

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076729
Enrollment
Unknown
Registered
2023-10-17
Start date
2023-10-20
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Sponsors

Hebei University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: ? meet DSM-5 diagnostic criteria; ? age between 18 and 50 years old (including 18 and 50 years old), regardless of gender; (3) the Pittsburgh sleep index (PSQI) PittsburgSleepQualityIndex, scoring more than 7 points, insomnia severity index (ISI) InsomniaSeverityIndex, between 8 and 21 points (including 8 and 21 points); ? not receiving sedative and hypnotic drugs, psychotherapy or auricular acupoint therapy within 2 weeks before enrollment; ? Patients were informed of the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) patients with a history of psychiatric or bipolar disorder and the following major sleep disorders: sleep apnea (hypopnea index > 15), restless legs syndrome, periodic limb movement disorder (PLMSI > 15 events /h), circadian dysrhythmia, and parasomnia; ? Self-rating AnxietyScale (SAS) score greater than 69 (including 69), self-rating Depression scale (SDS) score greater than 72 (including 72); ? pregnant or lactating women; ? ear redness, ulceration, scar and allergic to tape; ? hemorrhagic diseases, coagulation disorders, hyperglycemia and anemia; ? patients unwilling to accept blood collection; ? Other clinical investigators are planned to be enrolled or have been enrolled.

Design outcomes

Primary

MeasureTime frame
proteomics;metabonomics;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index;insomnia severity index;self-rating anxiety scale;self-rating depression scale;

Countries

China

Contacts

Public ContactYanfen She

Hebei University of Chinese Medicine

sheyanfen@163.com+86 158 3395 5088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026